|
2025
|
Invention
|
Therapy for inhibition of single-stranded rna virus replication.
Pharmaceutical compositions sho... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory bowel disease, namely, Crohn's dise... |
|
2024
|
Invention
|
Combination therapy for inhibition of ebolavirus. Combination therapies for the inhibition of sin... |
|
|
Invention
|
Pharmaceutical compositions for the treatment of helicobacter pylori.
Single oral solid dosage f... |
|
|
Invention
|
Serine protease inhibitor for treating coronavirus infection.
The disclosure is directed to WX-6... |
|
2023
|
Invention
|
Method for eradicating helicobacter pylori infection in patients regardless of body mass index.
... |
|
|
P/S
|
Providing medical information regarding H. pylori infection and treatment thereof |
|
|
Invention
|
Therapy for inhibition of single-stranded rna virus replication. Pharmaceutical compositions show... |
|
2022
|
Invention
|
Biomarkers of coronavirus pneumonia. The disclosure is directed to ABC294640, as free base or as ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory and gastrointestinal diseases, anti... |
|
2021
|
Invention
|
Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients w... |
|
|
P/S
|
Providing medical information regarding pulmonary Mycobacterium avium Complex (MAC) disease and t... |
|
|
P/S
|
Providing medical information regarding pulmonary
Mycobacterium avium Complex (MAC) disease and ... |
|
|
Invention
|
Sphingosine kinase 2 inhibitor for treating coronavirus infection. The disclosure is directed to ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
inflammatory bowel disease, namely, Crohn's dis... |
|
|
Invention
|
Helicobacter pylori infection. H. pylori. |
|
|
Invention
|
Inhibitor of sphingosine kinase 2 for treating ebola. Pharmaceutical compositions showing the abi... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment and eradication of Helicobacter pylo... |
|
|
Invention
|
Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating... |
|
|
Invention
|
Sphingosine kinase 2 inhibitor for treating coronavirus infection.
The disclosure is directed to... |
|
|
P/S
|
Providing medical information regarding H. pylori infection
and treatment thereof. |
|
|
Invention
|
Serine protease inhibitor for treating coronavirus infection. The disclosure is directed to WX-67... |
|
|
Invention
|
Treatment of coronavirus infection. The disclosure relates generally to the fields of virology, i... |
|
|
Invention
|
Combination compositions for treatment of cancer. Provided are methods for treating cancer in a p... |
|
2020
|
Invention
|
Bimodal release ondansetron tablets and methods of treating nausea and vomiting.
A solid oral do... |
|
|
Invention
|
Helicobacter pylori infection in patients regardless of body mass index. Helicobacter pylori infe... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
and eradication of helicobacter pyl... |
|
|
Invention
|
Methods for treating diarrhea predominant irritable bowel syndrome.
A method of treating a patie... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
and eradication of Helicobacter pyl... |
|
|
Invention
|
Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine. Myco... |
|
|
Invention
|
Compositions for treating ebola virus infection. Pharmaceutical compositions showing the ability ... |
|
2019
|
Invention
|
Formulations and methods of manufacturing formulations for use in colonic evacuation. Formulation... |
|
|
Invention
|
Method for treating cancer with combination therapy. Provided are methods for treating cancer in ... |
|
|
Invention
|
Method for treating crohn's disease using triple antimicrobial all-in-one formulation. Mycobacter... |
|
|
Invention
|
Methods for treating helicobacter pylori infection. H. pylori. |
|
2018
|
Invention
|
Blister package |
|
|
Invention
|
Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprisin... |
|
|
Invention
|
Use of wx-uk1 and its prodrug, wx-671, for the treatment of non-cancerous medical conditions. The... |
|
|
Invention
|
Use of wx-uk1 and its prodrug, wx-671, for the treatment of non-cancerous medical conditions.
Th... |
|
|
P/S
|
Pharmaceutical preparations for treatment of H. pylori infections |
|
|
P/S
|
Pharmaceutical preparations for treatment of H. pylori
infections. |
|
2017
|
Invention
|
Combination therapies for treating cancer. Provided are methods for treating cancer in a patient ... |
|
|
Invention
|
Antiemetic extended release solid dosage forms.
A pharmaceutical formulation includes (1) a firs... |
|
|
Invention
|
Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome. A meth... |
|
|
Invention
|
Pharmaceutical compositions comprising three antibiotics. Mycobacterium avium subspecies paratube... |
|
|
Invention
|
Antiemetic extended release solid dosage forms.
A solid oral dosage form includes a core compris... |
|
|
Invention
|
Helicobacter pylori. H. pylori. |
|
2016
|
P/S
|
pharmaceutical preparations for treatment of H. pylori infections |
|
|
Invention
|
Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof.
Oral admini... |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of
inflammatory and gastrointestinal diseases, ant... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory bowel disease, namely, colitis and ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of inflammatory diseases, namely, colitis and Crohn... |
|
|
Invention
|
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea ... |
|
2014
|
P/S
|
pharmaceutical preparations for the treatment of inflammatory and gastrointestinal diseases, anti... |
|
2013
|
P/S
|
Pharmaceutical preparations for treatment of heart failure, left ventricular dysfunction and hype... |
|
|
P/S
|
[ Pharmaceutical preparations for treatment of heart failure, left ventricular dysfunction and hy... |
